From Caffeine To 'Healthy' Labeling, FDA Sets Year-End Agenda For US Food Supply

For example, the FDA plans to draft guidance on action levels for cadmium and inorganic arsenic in food products meant for ...
MedPage Today on MSN

FDA Expands Risankizumab Label in Psoriatic Disease

IL-23 inhibitor lands indications for kids 6 years and up ...

CAPR Stock Hits Over 4-Month Low: Capricor Execs Cash In $1.5M As FDA Sets Stage For DMD Drug Review

Capricor is working toward a potential FDA decision by Aug. 22, making the next two months a key regulatory stretch for CAPR ...
Regulatory Affairs Professionals Society

This Week at FDA: FDA names PreCheck participants, TAP open to all OHT devices, and more

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
GlobalData on MSN

FDA widens Vertex’s Casgevy use for paediatric patients

Children as young as two with either sickle cell disease or thalassemia are now eligible for the gene therapy.

FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.

The Food and Drug Administration is meeting next month to consider easing restrictions on several peptides, a group of ...
Morning Overview on MSN

The FDA just added a kidney-damage warning to a popular over-the-counter diet pill

Anyone who has picked up a box of alli from a drugstore shelf without a prescription now faces a new risk disclosure. The FDA ...
The Manila Times

Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)

FDA did not raise concerns regarding the clinical efficacy or safety data of OLC, and no additional data was requested --MOUNTAIN VIEW, Calif., June 30, 2026 (GLOBE NEWSWIRE) - ...
The Healthy on MSN

Wet Wipes Recall: 6.8 Million Get the Highest FDA Warning

Following consumer harm reports, 10 package varieties of a trusted store label product have been intercepted for concern of ...
MPR

Skyrizi Earns FDA Pediatric Approval for Psoriatic Disease in Patients Aged 6+

The expanded indication makes risankizumab the first IL-23 inhibitor available for pediatric patients weighing under 40kg with plaque psoriasis or psoriatic arthritis, supported by phase 3 OptIMMize ...
pharmaphorum

FDA clears Viridian's Tepezza rival for thyroid eye disease

Viridian Therapeutics has fired a shot across Amgen's bows with FDA approval of Lumvoa, the first direct rival to Amgen's ...

Maharashtra FDA Flags 3 Beauty Creams For Toxic Mercury & Lead, Issues Urgent Public Health Alert

Maharashtra Food and Drugs Administration has warned consumers after lab tests found mercury and lead above permissible limits in three cosmetic products, including Goree Beauty Cream, Face Fresh Gold ...